Showing results (161-170 of 433) with videos related to
Sort By:
Pageof 44
Leukemia & Lymphoma|September 1, 1996
Feasibility of randomised clinical trials in rare diseases: the case of polycythemia veraR Marchioli, R Landolfi, T Barbui, et al.Leukemia|July 30, 2003
Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cellsA Falanga, A Vignoli, M Marchetti, et al.British Journal of Haematology|November 1, 1991
A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpuraA Falanga, R Consonni, P Ruggenenti, et al.La Ricerca in Clinica E in Laboratorio|April 1, 1985
Prevalence of antithrombin III deficiency in blood donors selected for personal or familial history of venous thrombosisG Finazzi, E Radice, A Armato, et al.Acta Haematologica|January 1, 1983
Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapyT Barbui, F Rodeghiero, S Meli, et al.European Journal of Cancer & Clinical Oncology|July 1, 1986
Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol estersP Viero, S Cortelazzo, T Barbui, et al.La Ricerca in Clinica E in Laboratorio|October 1, 1982
Diagnostic and prognostic significance of platelet-bound IgG measurement in immune thrombocytopenic purpuraT Barbui, S Cortelazzo, C Casarotto, et al.The Cochrane Database of Systematic Reviews|October 19, 2007
Milk thistle for alcoholic and/or hepatitis B or C virus liver diseasesA Rambaldi, B P Jacobs, C GluudBone Marrow Transplantation|March 21, 2017
Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?F Lussana, M Di Ianni, A RambaldiBlood Cancer Journal|February 3, 2016
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisT Barbui, J Thiele, A M Vannucchi, et al.Pageof 44